Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KS.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KS.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MK.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
MK.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-5250.36France
MK.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
MK.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.1.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
KP.4.1.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
KP.4.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
KP.4.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
KP.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.7.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
LB.1.7.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
LB.1.7.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.7.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.7.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.42.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
JN.1.42.2ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
JN.1.42.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.42.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.42.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LA.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
LA.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
LA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LF.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
LF.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
LF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
KP.4ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
KP.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.16ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
KP.2.16ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-15630.5France
KP.2.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.2.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
XBB.1ORF1abPasteur-ORF1ab-1CTCCCTTTGTTGTGTTGT1844.441279712780R-18837.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used